These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7332609)

  • 1. Metabolic studies with probucol in hypercholesterolaemia.
    Simons LA; Balasubramaniam S; Beins DM
    Atherosclerosis; 1981; 40(3-4):299-308. PubMed ID: 7332609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of probucol on cholesterol and lipoprotein metabolism in man.
    Kesäniemi YA; Grundy SM
    J Lipid Res; 1984 Aug; 25(8):780-90. PubMed ID: 6491523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of probucol on plasma lipoproteins in polygenic and familial hypercholesterolaemia.
    Cortese C; Marenah CB; Miller NE; Lewis B
    Atherosclerosis; 1982 Sep; 44(3):319-25. PubMed ID: 7150396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Probucol: mechanism of action (author's transl)].
    Infante R
    Nouv Presse Med; 1980 Oct; 9(40):2976-80. PubMed ID: 7443434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hypolipidemic action of probucol. Drug transport and lipoprotein composition in type IIa hyperlipoproteinemia.
    Dachet C; Jacotot B; Buxtorf JC
    Atherosclerosis; 1985 Dec; 58(1-3):261-8. PubMed ID: 4091882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of probucol on lipoprotein protein kinetics.
    Nestel PJ
    Artery; 1982; 10(2):95-8. PubMed ID: 7092582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probucol: effects on the metabolism of low density and high density lipoproteins in moderate hypercholesterolaemia.
    Magill P; Whiting C; Hammett F; Glick I; Miller NE; Lewis B
    Artery; 1982; 10(2):88-94. PubMed ID: 7092581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of severe and mild hypercholesterolaemia with probucol and neomycin.
    Miettinen TA; Toivonen I
    Postgrad Med J; 1975; 51(8):suppl 71-5. PubMed ID: 215985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of probucol on serum lipoprotein levels in normal and dyslipoproteinemic mice.
    Tomikawa M; Nakayasu T; Tawara K; Abiko Y
    Atherosclerosis; 1981 Oct; 40(2):101-13. PubMed ID: 6946776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mode of hypocholesterolemic action of probucol in animals and man.
    Beynen AC
    Artery; 1987; 14(2):113-26. PubMed ID: 3551883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of probucol on low density lipoprotein removal and high density lipoprotein synthesis.
    Nestel PJ; Billington T
    Atherosclerosis; 1981; 38(1-2):203-9. PubMed ID: 7470200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of probucol treatment on lipoprotein cholesterol and drug levels in blood and lipoproteins in familial hypercholesterolemia.
    Fellin R; Gasparotto A; Valerio G; Baiocchi MR; Padrini R; Lamon S; Vitale E; Baggio G; Crepaldi G
    Atherosclerosis; 1986 Jan; 59(1):47-56. PubMed ID: 3081013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probucol treatment in hypercholesterolemic patients: effects on lipoprotein composition, HDL particle size, and cholesteryl ester transfer.
    Bagdade JD; Kaufman D; Ritter MC; Subbaiah PV
    Atherosclerosis; 1990 Oct; 84(2-3):145-54. PubMed ID: 2282096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of probucol on plasma lipids, lipoproteins and parameters of high density lipoprotein metabolism.
    Wetterau JR; Combs KA; Albers HW; Lamkin G; Stein EA; Barnhart RL; Chi EM; Jackson RL; Harmony JA
    Horm Metab Res; 1992 Jun; 24(6):289-96. PubMed ID: 1634195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of cholestyramine and probucol in the treatment of familial hypercholesterolaemia.
    Jones DB; Simpson HC; Slaughter P; Lousley S; Carter RD; Cobbe SM; Mann JI
    Atherosclerosis; 1984 Oct; 53(1):1-7. PubMed ID: 6388586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of probucol on the composition of lipoproteins and on VLDL apoprotein B turnover.
    Lock DR; Kuisk I; Gonen B; Patsch W; Schonfeld G
    Atherosclerosis; 1983 Jun; 47(3):271-8. PubMed ID: 6882500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of probucol on cholesterol synthesis, plasma lipoproteins and the activities of lipoprotein and hepatic lipase in the rat.
    Strandberg T; Kuusi T; Tilvis R; Miettinen TA
    Atherosclerosis; 1981; 40(3-4):193-201. PubMed ID: 7332600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diet and probucol in lowering cholesterol concentrations. Additive effects on plasma cholesterol concentrations in patients with familial type ii hyperlipoproteinemia.
    LeLorier J; DuBreuil-Quidoz S; Lussier-Cacan S; Huang YS; Davignon J
    Arch Intern Med; 1977 Oct; 137(10):1429-34. PubMed ID: 335998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probucol in hypercholesterolemia. A double blind study.
    Riesen WF; Keller M; Mordasini R
    Atherosclerosis; 1980 Jun; 36(2):201-7. PubMed ID: 7406949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of probucol on cholesteryl ester transport.
    Chiesa G; Franceschini G; Sirtori CR
    Biochim Biophys Acta; 1990 Aug; 1045(3):302-4. PubMed ID: 2386803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.